Evidence map›Paper›PMID 28421418›Full record

ArticleEndocrine2018

Lower urinary tract symptoms (LUTS) in males with type 2 diabetes recently treated with SGLT2 inhibitors-overlooked and overwhelming? A retrospective case series.

Nino Cristiano Chilelli, Giuseppe Bax, Giulio Bonaldo, Eugenio Ragazzi, Massimo Iafrate, Filiberto Zattoni, Federico Bellavere, Annunziata Lapolla

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Autonomic neuropathy in diabetes.Archives of endocrinology and metabolism · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nino Cristiano ChilelliDiabetology and Dietetics Unit, Department of Medicine, University of Padova, Padova, Italy.
Giuseppe BaxDiabetology and Dietetics Unit, Department of Medicine, University of Padova, Padova, Italy.
Giulio BonaldoUrology Clinic, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy.
Eugenio RagazziDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Massimo IafrateUrology Clinic, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy.
Filiberto ZattoniUrology Clinic, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy.
Federico BellavereRizzola Foundation Hospital, Venezia, Italy.
Annunziata LapollaDiabetology and Dietetics Unit, Department of Medicine, University of Padova, Padova, Italy. annunziata.lapolla@unipd.it.ORCID http://orcid.org/0000-0002-9207-7704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Sodium-Glucose Transporter 2 InhibitorsDiabetes Mellitus, Type 2HumansHypoglycemic AgentsLower Urinary Tract SymptomsMaleMiddle AgedRetrospective StudiesHypoglycemic AgentsSodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID28421418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.